Business NewsPR NewsWire • Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment

Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment

Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment

NEW BRUNSWICK, N.J., June 14, 2011 /PRNewswire-USNewswire/ -- Psoriasis is a persistent, long-lasting chronic skin disease affecting 2-3 percent of the world's population or more than 125 million individuals.  For some, it is just a nuisance. For others, it is disabling. On a continuing quest t

View More : http://www.prnewswire.com/news-releases/actinobac-biomed-inc-demonstrates-in-vivo-efficacy-for-psoriasis-treatment-12383...
Releted News by prnewswire
Carlisle Introduces Watermill Flooring
The Hunt for Extraterrestrial Life Moves From Science Fiction to Real World Science
NeuroFocus CEO Dr. A.K. Pradeep Named Finalist for Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award
Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment
Arch Coal's Mountain Laurel Mining Complex Named ESGR Pro Patria Award Recipient for West Virginia